BVNA president begins second term
“Progression can be so very much, but what it should do is make us look at what we could be doing better for ourselves and those around us” – Lyndsay Hughes.
Lyndsay Hughes has begun her second term as president of the British Veterinary Nursing Association (BVNA).
Speaking at the BVNA’s annual general meeting (AGM) during last month’s BVNA Congress, Ms Hughes explained that the association planned to continue with the theme of ‘progression’ from her first term.
Ms Hughes said: “I stand before you again this year, asking the same of you as I did last year – this is your profession, and I will dutifully stand and serve you and speak on your behalf, as loudly as I can and wherever I can.
“But – I need every single one of you to engage with the work being undertaken. Whether that is by me, the association or by engaging with anything that can impact you as a veterinary nurse. You have the power to help make the changes, we are stronger together and always will be.
“The progression of our profession touches so many elements. This could be leadership, this could be clinic development, QI, non-clinical roles, it can even be as I’ve just mentioned the progression of our mindset.
“Progression can be so very much, but what it should do is make us look at what we could be doing better for ourselves and those around us. For those that are already developing each other and supporting progression of veterinary nurses, then we must celebrate you and share your experiences to help others.”
The BVNA’s officer team for the 2024-25 year has also been ratified. Alongside Ms Hughes as president, Sarah Holliday will serve as junior vice-president, Nikki McLeod as honorary treasurer, and Steph Worsley as honorary secretary.
The congress also saw three new recently elected council members begin their three-year terms: Simone Bennett, Hamish Morris, and Helen Stewart.
Image © BVNA
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
